Raxone

Early access to Santhera’s DMD therapy Raxone extended in the UK
Pharma Times
Fri, 06/22/18 - 10:26 pm
UK
Santhera
Raxone
Duchenne Muscular Dystrophy
Sarepta Stock Slides As FDA Sends Another Bad Signal On DMD
Investors.com
Fri, 07/15/16 - 10:15 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
Raxone
Kyndrisa
Santhera
Duchenne Drug Developer (Not Sarepta) Hit with Lengthy FDA Delay
TheStreet.com
Thu, 07/14/16 - 09:20 am
Raxone
Duchenne Muscular Dystrophy
Santhera